Go Pro
→ SpaceX IPO hides a much bigger story (From Weiss Ratings) (Ad)tc pixel Free HTFL Stock Alerts

Heartflow (HTFL) Competitors

Heartflow logo
$25.44 +0.88 (+3.58%)
Closing price 04:00 PM Eastern
Extended Trading
$25.43 -0.01 (-0.04%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

HTFL vs. HIMS, PACS, BLLN, SHC, and RDNT

Should you buy Heartflow stock or one of its competitors? MarketBeat compares Heartflow with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Heartflow include Hims & Hers Health (HIMS), PACS Group (PACS), Billiontoone (BLLN), Sotera Health (SHC), and RadNet (RDNT). These companies are all part of the "healthcare" industry.

How does Heartflow compare to Hims & Hers Health?

Heartflow (NASDAQ:HTFL) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M12.46-$116.79M-$3.11N/A
Hims & Hers Health$2.35B3.23$128.37M-$0.09N/A

Hims & Hers Health has a net margin of -0.56% compared to Heartflow's net margin of -58.42%. Hims & Hers Health's return on equity of 6.10% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Heartflow-58.42% N/A -20.02%
Hims & Hers Health -0.56%6.10%1.52%

63.5% of Hims & Hers Health shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 5 more articles in the media than Heartflow. MarketBeat recorded 7 mentions for Hims & Hers Health and 2 mentions for Heartflow. Hims & Hers Health's average media sentiment score of 0.68 beat Heartflow's score of 0.24 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hims & Hers Health
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Heartflow presently has a consensus price target of $37.00, indicating a potential upside of 45.44%. Hims & Hers Health has a consensus price target of $30.70, indicating a potential downside of 6.38%. Given Heartflow's stronger consensus rating and higher probable upside, research analysts plainly believe Heartflow is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19

Summary

Hims & Hers Health beats Heartflow on 10 of the 16 factors compared between the two stocks.

How does Heartflow compare to PACS Group?

Heartflow (NASDAQ:HTFL) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends.

In the previous week, Heartflow and Heartflow both had 2 articles in the media. PACS Group's average media sentiment score of 0.39 beat Heartflow's score of 0.24 indicating that PACS Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PACS Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Heartflow presently has a consensus price target of $37.00, indicating a potential upside of 45.44%. PACS Group has a consensus price target of $50.60, indicating a potential upside of 11.00%. Given Heartflow's higher probable upside, equities research analysts plainly believe Heartflow is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M12.46-$116.79M-$3.11N/A
PACS Group$5.29B1.36$191.54M$1.5629.22

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -58.42%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Heartflow-58.42% N/A -20.02%
PACS Group 4.49%26.47%4.36%

Summary

PACS Group beats Heartflow on 9 of the 13 factors compared between the two stocks.

How does Heartflow compare to Billiontoone?

Heartflow (NASDAQ:HTFL) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

Heartflow presently has a consensus target price of $37.00, indicating a potential upside of 45.44%. Billiontoone has a consensus target price of $126.00, indicating a potential downside of 4.79%. Given Heartflow's stronger consensus rating and higher possible upside, equities analysts clearly believe Heartflow is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Billiontoone has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M12.46-$116.79M-$3.11N/A
Billiontoone$354.54M17.17$7.45M$0.55240.62

Billiontoone has a net margin of 0.00% compared to Heartflow's net margin of -58.42%.

Company Net Margins Return on Equity Return on Assets
Heartflow-58.42% N/A -20.02%
Billiontoone N/A N/A N/A

In the previous week, Billiontoone had 1 more articles in the media than Heartflow. MarketBeat recorded 3 mentions for Billiontoone and 2 mentions for Heartflow. Billiontoone's average media sentiment score of 0.57 beat Heartflow's score of 0.24 indicating that Billiontoone is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Billiontoone
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Billiontoone beats Heartflow on 9 of the 12 factors compared between the two stocks.

How does Heartflow compare to Sotera Health?

Heartflow (NASDAQ:HTFL) and Sotera Health (NASDAQ:SHC) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Heartflow currently has a consensus target price of $37.00, suggesting a potential upside of 45.44%. Sotera Health has a consensus target price of $20.25, suggesting a potential upside of 16.38%. Given Heartflow's higher probable upside, analysts plainly believe Heartflow is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

In the previous week, Sotera Health had 1 more articles in the media than Heartflow. MarketBeat recorded 3 mentions for Sotera Health and 2 mentions for Heartflow. Sotera Health's average media sentiment score of 1.73 beat Heartflow's score of 0.24 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Heartflow
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sotera Health
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Sotera Health has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heartflow$176.03M12.46-$116.79M-$3.11N/A
Sotera Health$1.16B4.26$77.94M$0.4142.44

91.0% of Sotera Health shares are held by institutional investors. 7.7% of Heartflow shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sotera Health has a net margin of 9.91% compared to Heartflow's net margin of -58.42%. Sotera Health's return on equity of 39.73% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
Heartflow-58.42% N/A -20.02%
Sotera Health 9.91%39.73%7.05%

Summary

Sotera Health beats Heartflow on 13 of the 16 factors compared between the two stocks.

How does Heartflow compare to RadNet?

RadNet (NASDAQ:RDNT) and Heartflow (NASDAQ:HTFL) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

In the previous week, RadNet had 6 more articles in the media than Heartflow. MarketBeat recorded 8 mentions for RadNet and 2 mentions for Heartflow. RadNet's average media sentiment score of 0.92 beat Heartflow's score of 0.24 indicating that RadNet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Heartflow
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Comparatively, 7.7% of Heartflow shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

RadNet has a net margin of -0.66% compared to Heartflow's net margin of -58.42%. RadNet's return on equity of 2.77% beat Heartflow's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.66% 2.77% 0.97%
Heartflow -58.42%N/A -20.02%

RadNet presently has a consensus price target of $87.43, suggesting a potential upside of 41.31%. Heartflow has a consensus price target of $37.00, suggesting a potential upside of 45.44%. Given Heartflow's higher possible upside, analysts clearly believe Heartflow is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.80
Heartflow
1 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.70

RadNet has higher revenue and earnings than Heartflow. RadNet is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.38-$18.65M-$0.18N/A
Heartflow$176.03M12.46-$116.79M-$3.11N/A

Summary

RadNet beats Heartflow on 11 of the 15 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTFL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTFL vs. The Competition

Export
MetricHeartflowHealth Information Services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.19B$1.04B$6.81B$12.41B
Dividend YieldN/A6.04%2.67%9.39%
P/E Ratio-8.18301.2127.0024.19
Price / Sales12.46133.90518.8494.59
Price / CashN/A47.1426.6847.25
Price / Book7.217.1010.676.26
Net Income-$116.79M-$22.78M$3.60B$331.76M
7 Day Performance-0.20%-2.44%-0.37%-1.10%
1 Month Performance-24.38%-1.91%1.85%-1.27%
1 Year PerformanceN/A-11.27%25.51%18.85%

Heartflow Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTFL
Heartflow
3.0096 of 5 stars		$25.44
+3.6%		$37.00
+45.4%		N/A$2.19B$176.03MN/A699
HIMS
Hims & Hers Health
2.6966 of 5 stars		$33.63
-9.5%		$30.70
-8.7%		-35.1%$7.78B$2.37BN/A2,442
PACS
PACS Group
2.7736 of 5 stars		$45.52
+1.2%		$50.60
+11.2%		+273.7%$7.20B$5.43B29.1847,455
BLLN
Billiontoone
1.88 of 5 stars		$128.18
-1.3%		$126.00
-1.7%		N/A$5.89B$305.11M233.05620
SHC
Sotera Health
3.6739 of 5 stars		$18.27
+0.7%		$20.25
+10.8%		+57.5%$5.21B$1.19B44.563,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 7/21/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel